Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative.

Trial Profile

Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2015

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Breast cancer
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 30 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by University Hospital Medical Information Network - Japan.
    • 26 Jan 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan. (Parent trial: UMIN000003969)
    • 06 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top